Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis

2006/06/01 by Silvio Danese, Miquel Sans, Carol de la Motte +10 · 29 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Angiogenesis and VEGF in Cancer #Cell Adhesion Molecules Research

paper · pdf · doi:10.1053/j.gastro.2006.03.054

Cited by

• VEGF-C–dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease
• Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation
• Angiogenesis and chronic inflammation: cause or consequence?
• Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions
• Mechanisms of disease: protease functions in intestinal mucosal pathobiology. [europepmc]
• Angiopoietin-2 in experimental colitis. [europepmc]
• Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. [europepmc]
• Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. [europepmc]
• Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. [europepmc]
• Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. [europepmc]
• Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. [europepmc]
• The cutaneous vascular system in chronic skin inflammation. [europepmc]
• Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis. [europepmc]
• PET imaging of inflammation biomarkers. [europepmc]
• MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. [europepmc]
• Mechanisms that mediate the development of fibrosis in patients with Crohn's disease. [europepmc]
• VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. [europepmc]
• Matrix metalloproteinases in inflammatory bowel disease: an update. [europepmc]
• Angiogenesis in Inflammatory Bowel Disease. [europepmc]
• Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis. [europepmc]
• Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. [europepmc]
• Role of contrast-enhanced ultrasound in evaluation of the bowel. [europepmc]
• Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis. [europepmc]
• IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. [europepmc]
• The relationship between the gut microbiome and host gene expression: a review. [europepmc]
• Pathological angiogenesis and inflammation in tissues. [europepmc]
• The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease. [europepmc]
• Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing. [europepmc]
• Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. [europepmc]